Clinical trials: Moderate Aplastic Anemia Requiring Transfusions

Idiopathic Aplastic Anemia, Severe Aplastic Anemia

Up-front Matched Unrelated Donor Transplantation in Pediatric Patients With Idiopathic Aplastic Anemia

• Not yet recruiting
• Age: Up to 18 years
• Phase 2
• Injection or infusion

Pediatric patients with idiopathic aplastic anemia (AA) respond better than adults to immunosuppressive therapy (IST) but the long-term risks of relapse, ciclosporine dependence, and clonal evolution are high.

Conditions

Idiopathic Aplastic Anemia, Severe Aplastic Anemia, Moderate Aplastic Anemia Requiring Transfusions

Trial name

UPFRONT-MUD (NCT05419843)

Testing

HSCT Arm group

Volunteers

25 people

Sponsor

Assistance Publique - Hôpitaux de Paris